These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2076729)

  • 21. Removal of 10-hydroxycarbazepine by plasmapheresis.
    Christensen J; Balslev T; Villadsen J; Heinsvig EM; Dam M; Poulsen JH
    Ther Drug Monit; 2001 Aug; 23(4):374-9. PubMed ID: 11477319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
    Besi E; Boniface DR; Cregg R; Zakrzewska JM
    J Headache Pain; 2015; 16():563. PubMed ID: 26335440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity.
    Zakrzewska JM; Ivanyi L
    J Allergy Clin Immunol; 1988 Jul; 82(1):110-5. PubMed ID: 3392362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory trigeminal neuralgia. Non-surgical treatment options.
    Cruccu G; Truini A
    CNS Drugs; 2013 Feb; 27(2):91-6. PubMed ID: 23225488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.
    Linnet K; Steentoft A; Simonsen KW; Sabers A; Hansen SH
    Forensic Sci Int; 2008 May; 177(2-3):248-51. PubMed ID: 18036757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS).
    Kłys M; Rojek S; Bolechała F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):38-46. PubMed ID: 16154521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
    Antunes NJ; van Dijkman SC; Lanchote VL; Wichert-Ana L; Coelho EB; Alexandre Junior V; Takayanagui OM; Tozatto E; van Hasselt JGC; Della Pasqua O
    Eur J Pharm Sci; 2017 Nov; 109S():S116-S123. PubMed ID: 28528287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
    Bertilsson L; Tomson T
    Clin Pharmacokinet; 1986; 11(3):177-98. PubMed ID: 3524954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia.
    Tomson T; Bertilsson L
    Arch Neurol; 1984 Jun; 41(6):598-601. PubMed ID: 6721732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy.
    Kurul S; Dirik E; Iscan A
    J Child Neurol; 2003 Aug; 18(8):552-4. PubMed ID: 13677582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxycarbazepine distribution in three postmortem cases.
    Levine B; Green-Johnson D; Moore KA; Fowler DR
    J Anal Toxicol; 2004 Sep; 28(6):509-11. PubMed ID: 15516305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Poletti-Jabbour J; Wiegering-Rospigliosi A; Pereyra-Elías R; Elías-Barrera CC
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1031-2. PubMed ID: 27130345
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantification of oxcarbazeipine and its active metabolite 10-hydroxycarbazepine in human plasma by high-performance liquid chromatography.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Ajjala DR
    Arzneimittelforschung; 2006; 56(7):517-23. PubMed ID: 16927533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of carbamazepine in trigeminal neuralgia].
    Puzin Mn; Martynova LA; Sharov MN; Zherdev VP; Starose'lskaia IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(6):105-8. PubMed ID: 2675510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Unexpected loss of therapeutic effect of oxcarbazepine].
    Lampert ML; Rätz Bravo AE; Brugger S; Haschke M
    Praxis (Bern 1994); 2007 Nov; 96(47):1843-8. PubMed ID: 18062156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine.
    Elyas AA; Goldberg VD; Patsalos PN
    J Chromatogr; 1990 Jun; 528(2):473-9. PubMed ID: 2384584
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
    Malátková P; Havlíková L; Wsól V
    Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.